Foghorn Therapeutics logo

Foghorn Therapeutics

FHTX | NASDAQ
Chart Builder DCF Calculator
$1.79
-$0.28 (-13.53%)
At close: Nov 16, 2026, 4:00 PM ET
$1.76
-$0.03 (-1.68%)
After-hours: Nov 16, 2026, 4:34 PM ET
-13.53%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
62.5
Fundamentals Strong
Market Sentiment Neutral
Moat None
Sector Rank #111/1021 (Top 11%)

Key Statistics

Market Data

Market Cap $127.91M
1D Range
1.77 2.05
52W Range
1.76 7.07

Valuation (TTM)

PE 29.83
PB -9.08
EV/EBITDA 1.43

Valuation (NTM)

Forward PE N/A
Forward PEG -0.32
Price Target $5.00
Loading financial charts...

Profile

Foghorn Therapeutics Inc. is a clinical-stage biopharmaceutical company dedicated to discovering and developing medicines. Their focus is on addressing genetically determined vulnerabilities within th...

Sector Healthcare
Industry Biotechnology
Employees 106
IPO Date Oct 23, 2020
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 9, 2026
EPS
$0.8
Beat +439.62%
REV
$83.54M
Beat +1077.13%
Next Earnings
Mar 10, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
6
Consensus
Hold
Price Target
$5.00
Upside
+179.33%
Buy (3)
Hold (3)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.